I

Intensity Therapeutics Inc
NASDAQ:INTS

Watchlist Manager
Intensity Therapeutics Inc
NASDAQ:INTS
Watchlist
Price: 0.32 USD 4.23% Market Closed
Market Cap: 8.3m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of INTS.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INTS Intrinsic Value
Not Available
I
Base Case Scenario
Compare INTS to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about INTS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Intensity Therapeutics Inc
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Intensity Therapeutics Inc

Balance Sheet Decomposition
Intensity Therapeutics Inc

Current Assets 1.7m
Cash & Short-Term Investments 929k
Other Current Assets 722k
Non-Current Assets 1.4m
PP&E 116k
Other Non-Current Assets 1.3m
Efficiency

Free Cash Flow Analysis
Intensity Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Intensity Therapeutics Inc

Revenue
0 USD
Operating Expenses
-15.2m USD
Operating Income
-15.2m USD
Other Expenses
224k USD
Net Income
-15m USD
Fundamental Scores

INTS Profitability Score
Profitability Due Diligence

Intensity Therapeutics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
26/100
Profitability
Score

Intensity Therapeutics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

INTS Solvency Score
Solvency Due Diligence

Intensity Therapeutics Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
45/100
Solvency
Score

Intensity Therapeutics Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INTS Price Targets Summary
Intensity Therapeutics Inc

There are no price targets for INTS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Intensity Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for INTS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y